Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.

Ueda T, Koga Y, Yoshikawa H, Tanabe M, Yamana K, Oba U, Nakashima K, Ono H, Ichimura T, Hasegawa S, Kato W, Kobayashi T, Nakayama H, Sakai Y, Yoshitake T, Ohga S, Oda Y, Suzuki S, Sonoda KH, Ohga S.

BMC Pediatr. 2020 Jan 28;20(1):37. doi: 10.1186/s12887-020-1923-7.

2.

Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study.

Aoyama T, Tsunoda T, Kato H, Hagino A, Furutani R, Ito K, Yoshioka H, Nakamura M, Hiraide M, Kawakami K, Kobayashi K, Suzuki K, Ichimura T, Yamaguchi K, Hama T.

J Chemother. 2020 Jan 21:1-7. doi: 10.1080/1120009X.2020.1713507. [Epub ahead of print]

PMID:
31960769
3.

Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival.

Ota Y, Takahari D, Suzuki T, Osumi H, Nakayama I, Oki A, Wakatsuki T, Ichimura T, Ogura M, Shinozaki E, Suenaga M, Chin K, Yamaguchi K.

Cancer Chemother Pharmacol. 2020 Feb;85(2):265-272. doi: 10.1007/s00280-019-04023-w. Epub 2020 Jan 6.

PMID:
31907646
4.

Surge of serum interleukin-2 level in a Japanese patient with cytarabine syndrome.

Iida Y, Yasudo H, Fukano R, Azuma Y, Ichimura T, Ohga S, Hasegawa S.

Pediatr Blood Cancer. 2020 Mar;67(3):e28131. doi: 10.1002/pbc.28131. Epub 2019 Dec 18. No abstract available.

PMID:
31850653
5.

Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma.

Suzuki T, Okamura A, Watanabe M, Mine S, Imamura Y, Asari T, Osumi H, Nakayama I, Ichimura T, Ogura M, Ooki A, Takahari D, Yamaguchi K, Chin K.

Ann Surg Oncol. 2019 Dec 9. doi: 10.1245/s10434-019-08124-x. [Epub ahead of print]

PMID:
31820213
6.

Linking substrate and nucleus via actin cytoskeleton in pluripotency maintenance of mouse embryonic stem cells.

David BG, Fujita H, Yasuda K, Okamoto K, Panina Y, Ichinose J, Sato O, Horie M, Ichimura T, Okada Y, Watanabe TM.

Stem Cell Res. 2019 Dec;41:101614. doi: 10.1016/j.scr.2019.101614. Epub 2019 Oct 24.

7.

Second harmonic generation polarization microscopy as a tool for protein structure analysis.

Kaneshiro J, Okada Y, Shima T, Tsujii M, Imada K, Ichimura T, Watanabe TM.

Biophys Physicobiol. 2019 Sep 20;16:147-157. doi: 10.2142/biophysico.16.0_147. eCollection 2019.

8.

An Ionic Liquid-Based Sample Preparation Method for Next-Stage Aggregate Proteomic Analysis.

Taoka M, Horita K, Takekiyo T, Uekita T, Yoshimura Y, Ichimura T.

Anal Chem. 2019 Nov 5;91(21):13494-13500. doi: 10.1021/acs.analchem.9b02555. Epub 2019 Oct 16.

PMID:
31617705
9.

Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses.

Kishi S, Brooks CR, Taguchi K, Ichimura T, Mori Y, Akinfolarin A, Gupta N, Galichon P, Elias BC, Suzuki T, Wang Q, Gewin L, Morizane R, Bonventre JV.

J Clin Invest. 2019 Nov 1;129(11):4797-4816. doi: 10.1172/JCI122313.

10.

Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration.

Sawayama T, Nakashima K, Ichimura T, Sakai R, Uekita T.

Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7271. [Epub ahead of print]

PMID:
31524271
11.

Comparison of MR imaging features of uterine neuroendocrine carcinoma and uterine malignant lymphoma.

Sugimoto M, Koyama K, Ichimura T, Shimono T, Hashiguchi Y, Miki Y.

Abdom Radiol (NY). 2019 Oct;44(10):3377-3387. doi: 10.1007/s00261-019-02201-1.

PMID:
31473773
12.

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.

Goldman A, Khiste S, Freinkman E, Dhawan A, Majumder B, Mondal J, Pinkerton AB, Eton E, Medhi R, Chandrasekar V, Rahman MM, Ichimura T, Gopinath KS, Majumder P, Kohandel M, Sengupta S.

Sci Signal. 2019 Aug 20;12(595). pii: eaas8779. doi: 10.1126/scisignal.aas8779.

PMID:
31431543
13.

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study.

Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Manag Res. 2019 Jun 25;11:5757-5764. doi: 10.2147/CMAR.S201048. eCollection 2019.

14.

Profiling of Target Molecules for Immunotherapy in Mesenchymal Tumors.

Hayashi T, Ichimura T, Sano K, Tonegawa S, Kanai Y, Zharhary D, Aburatani H, Yaegashi N, Konishi I.

J Clin Med Res. 2019 Aug;11(8):609-613. doi: 10.14740/jocmr3886. Epub 2019 Jul 27. No abstract available.

15.

Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.

Tenjin Y, Kudoh S, Kubota S, Yamada T, Matsuo A, Sato Y, Ichimura T, Kohrogi H, Sashida G, Sakagami T, Ito T.

Lab Invest. 2019 Nov;99(11):1622-1635. doi: 10.1038/s41374-019-0277-y. Epub 2019 Jun 23.

PMID:
31231131
16.

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.

Suzuki T, Shinozaki E, Osumi H, Nakayama I, Ota Y, Ichimura T, Ogura M, Wakatsuki T, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Chemother Pharmacol. 2019 Aug;84(2):307-313. doi: 10.1007/s00280-019-03855-w. Epub 2019 May 7.

PMID:
31065729
17.

Endoscopic Features and Diagnostic Procedures of Eosinophilic Gastroenteritis.

Ashitani K, Tsuzuki Y, Yamaoka M, Ohgo H, Ichimura T, Kusano T, Nakayama T, Nakamoto H, Imaeda H.

Intern Med. 2019 Aug 1;58(15):2167-2171. doi: 10.2169/internalmedicine.2298-18. Epub 2019 Apr 17.

18.

Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.

Osumi H, Shinozaki E, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Takahari D, Ooki A, Suzuki T, Ota Y, Nakayama I, Chin K, Miki Y, Yamaguchi K.

Int J Cancer. 2019 Nov 1;145(9):2488-2495. doi: 10.1002/ijc.32320. Epub 2019 May 7.

PMID:
30963570
19.

Acute rheumatic fever associated with tenosynovitis and a unique cytokine profile.

Wakiguchi H, Okazaki F, Suzuki Y, Ichimura T, Wakabayashi-Takahara M, Terachi SI, Ouchi K, Hasegawa S.

Immunol Med. 2018 Mar;41(1):43-45. doi: 10.1080/09114300.2018.1451617. Epub 2018 Apr 3.

PMID:
30938255
20.

Rapid mantle flow with power-law creep explains deformation after the 2011 Tohoku mega-quake.

Agata R, Barbot SD, Fujita K, Hyodo M, Iinuma T, Nakata R, Ichimura T, Hori T.

Nat Commun. 2019 Mar 26;10(1):1385. doi: 10.1038/s41467-019-08984-7.

21.

Urine podoplanin heralds the onset of ischemia-reperfusion injury of the kidney.

Kasinath V, Yilmam OA, Uehara M, Yonar M, Jiang L, Li X, Qiu W, Eskandari S, Ichimura T, Abdi R.

Am J Physiol Renal Physiol. 2019 May 1;316(5):F957-F965. doi: 10.1152/ajprenal.00538.2018. Epub 2019 Mar 13.

PMID:
30864839
22.

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.

Suenaga M, Wakatsuki T, Mashima T, Ogura M, Ichimura T, Shinozaki E, Nakayama I, Osumi H, Ota Y, Takahari D, Chin K, Seimiya H, Yamaguchi K.

Invest New Drugs. 2020 Feb;38(1):111-119. doi: 10.1007/s10637-019-00749-9. Epub 2019 Mar 6.

PMID:
30838483
23.

Cyclin G1 and TASCC regulate kidney epithelial cell G2-M arrest and fibrotic maladaptive repair.

Canaud G, Brooks CR, Kishi S, Taguchi K, Nishimura K, Magassa S, Scott A, Hsiao LL, Ichimura T, Terzi F, Yang L, Bonventre JV.

Sci Transl Med. 2019 Jan 23;11(476). pii: eaav4754. doi: 10.1126/scitranslmed.aav4754.

24.

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.

Osumi H, Shinozaki E, Takeda Y, Wakatsuki T, Ichimura T, Saiura A, Yamaguchi K, Takahashi S, Noda T, Zembutsu H.

Cancer Med. 2019 Jan;8(1):408-417. doi: 10.1002/cam4.1913. Epub 2018 Dec 21.

25.

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake.

Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K.

Onco Targets Ther. 2018 Nov 23;11:8301-8307. doi: 10.2147/OTT.S184665. eCollection 2018.

26.

Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery.

Bahmani B, Uehara M, Ordikhani F, Li X, Jiang L, Banouni N, Ichimura T, Kasinath V, Eskandari SK, Annabi N, Bromberg JS, Shultz LD, Greiner DL, Abdi R.

EBioMedicine. 2018 Dec;38:79-88. doi: 10.1016/j.ebiom.2018.11.030. Epub 2018 Nov 27.

27.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):526. doi: 10.1007/s10120-018-0900-4.

28.

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer.

Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K.

Cancer Manag Res. 2018 Nov 1;10:5283-5290. doi: 10.2147/CMAR.S179219. eCollection 2018.

29.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):518-525. doi: 10.1007/s10120-018-0887-x. Epub 2018 Oct 17. Erratum in: Gastric Cancer. 2018 Nov 22;:.

30.

Kinesin-binding-triggered conformation switching of microtubules contributes to polarized transport.

Shima T, Morikawa M, Kaneshiro J, Kambara T, Kamimura S, Yagi T, Iwamoto H, Uemura S, Shigematsu H, Shirouzu M, Ichimura T, Watanabe TM, Nitta R, Okada Y, Hirokawa N.

J Cell Biol. 2018 Dec 3;217(12):4164-4183. doi: 10.1083/jcb.201711178. Epub 2018 Oct 8.

31.

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab.

Ushida Y, Shinozaki E, Chin K, Suenaga M, Takahari D, Ozaka M, Ogura M, Ichimura T, Wakatsuki T, Yamaguchi K.

Case Rep Oncol. 2018 Aug 29;11(2):601-608. doi: 10.1159/000492568. eCollection 2018 May-Aug.

32.

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, Solhjou Z, Furtmüller GJ, Brandacher G, Alvarez D, von Andrian UH, Uchimura K, Xu Q, Vohra I, Yilmam OA, Haik Y, Azzi J, Kasinath V, Bromberg JS, McGrath MM, Abdi R.

J Clin Invest. 2018 Nov 1;128(11):4770-4786. doi: 10.1172/JCI120923. Epub 2018 Oct 2.

33.

Raman spectral signature reflects transcriptomic features of antibiotic resistance in Escherichia coli.

Germond A, Ichimura T, Horinouchi T, Fujita H, Furusawa C, Watanabe TM.

Commun Biol. 2018 Jul 2;1:85. doi: 10.1038/s42003-018-0093-8. eCollection 2018.

34.

Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer.

Yoshikawa K, Fukuda T, Uemura R, Matsubara H, Wada T, Kawanishi M, Tasaka R, Kasai M, Hashiguchi Y, Ichimura T, Yasui T, Sumi T.

Mol Clin Oncol. 2018 Sep;9(3):329-334. doi: 10.3892/mco.2018.1668. Epub 2018 Jul 9.

35.

Cell type discrimination based on image features of molecular component distribution.

Germond A, Ichimura T, Chiu LD, Fujita K, Watanabe TM, Fujita H.

Sci Rep. 2018 Aug 6;8(1):11726. doi: 10.1038/s41598-018-30276-1.

36.

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.

Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K.

Cancer Sci. 2018 Aug;109(8):2567-2575. doi: 10.1111/cas.13698. Epub 2018 Jul 13.

37.

Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.

Yagi A, Ueda Y, Tanaka Y, Nakae R, Kakubari R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Matsumura N, Yoshino K, Kimura T, Saito J, Ikeda S, Asai-Sato M, Miyagi E, Sekine M, Enomoto T, Hirai K, Horikoshi Y, Takagi T, Shimura K.

Hum Vaccin Immunother. 2018;14(10):2497-2502. doi: 10.1080/21645515.2018.1480240. Epub 2018 Jun 29.

38.

Examination of the use of needle biopsy to perform laparoscopic surgery safely on uterine smooth muscle tumors.

Murakami M, Ichimura T, Kasai M, Matsuda M, Kawamura N, Fukuda T, Sumi T.

Oncol Lett. 2018 Jun;15(6):8647-8651. doi: 10.3892/ol.2018.8425. Epub 2018 Apr 4.

39.

Comparison of two instructions for deep breathing exercise: non-specific and diaphragmatic breathing.

Yokogawa M, Kurebayashi T, Ichimura T, Nishino M, Miaki H, Nakagawa T.

J Phys Ther Sci. 2018 Apr;30(4):614-618. doi: 10.1589/jpts.30.614. Epub 2018 Apr 20.

40.

The tremendous potential of deep-sea mud as a source of rare-earth elements.

Takaya Y, Yasukawa K, Kawasaki T, Fujinaga K, Ohta J, Usui Y, Nakamura K, Kimura JI, Chang Q, Hamada M, Dodbiba G, Nozaki T, Iijima K, Morisawa T, Kuwahara T, Ishida Y, Ichimura T, Kitazume M, Fujita T, Kato Y.

Sci Rep. 2018 Apr 10;8(1):5763. doi: 10.1038/s41598-018-23948-5.

41.

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.

Wakatsuki T, Yamamoto N, Sano T, Chin K, Kawachi H, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Matsushima T, Suenaga M, Shinozaki E, Hiki N, Ishikawa Y, Yamaguchi K.

J Gastroenterol. 2018 Nov;53(11):1186-1195. doi: 10.1007/s00535-018-1464-0. Epub 2018 Apr 9.

42.

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.

Fukuda N, Takahari D, Wakatsuki T, Osumi H, Nakayama I, Matsushima T, Ichimura T, Ogura M, Ozaka M, Suenaga M, Shinozaki E, Chin K, Yamaguchi K.

Oncotarget. 2018 Mar 8;9(20):15219-15227. doi: 10.18632/oncotarget.24635. eCollection 2018 Mar 16.

43.

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells.

Abe H, Saito R, Ichimura T, Iwasaki A, Yamazawa S, Shinozaki-Ushiku A, Morikawa T, Ushiku T, Yamashita H, Seto Y, Fukayama M.

Virchows Arch. 2018 Apr;472(4):643-651. doi: 10.1007/s00428-018-2332-2. Epub 2018 Mar 13.

PMID:
29536167
44.

Ischemia augments alloimmune injury through IL-6-driven CD4+ alloreactivity.

Uehara M, Solhjou Z, Banouni N, Kasinath V, Xiaqun Y, Dai L, Yilmam O, Yilmaz M, Ichimura T, Fiorina P, Martins PN, Ohori S, Guleria I, Maarouf OH, Tullius SG, McGrath MM, Abdi R.

Sci Rep. 2018 Feb 6;8(1):2461. doi: 10.1038/s41598-018-20858-4.

45.

A Sensitive Microbead-Based Organic Media-Assisted Method for Proteomics Sample Preparation from Dilute and Denaturing Solutions.

Taoka M, Fujii M, Tsuchiya M, Uekita T, Ichimura T.

ACS Appl Mater Interfaces. 2017 Dec 13;9(49):42661-42667. doi: 10.1021/acsami.7b16095. Epub 2017 Dec 4.

PMID:
29161009
46.

Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical Cancer Screening: A Randomized Study.

Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Asai-Sato M, Miyagi E, Sekine M, Enomoto T, Horikoshi Y, Takagi T, Shimura K.

J Epidemiol. 2018 Mar 5;28(3):156-160. doi: 10.2188/jea.JE20160155. Epub 2017 Nov 11.

47.

Feature analysis of cell nuclear chromatin distribution in support of cervical cytology.

Komagata H, Ichimura T, Matsuta Y, Ishikawa M, Shinoda K, Kobayashi N, Sasaki A.

J Med Imaging (Bellingham). 2017 Oct;4(4):047501. doi: 10.1117/1.JMI.4.4.047501. Epub 2017 Oct 17.

48.

Long-term survival after repeated resection of metachronous lung metastases from pStage IA pancreatic adenocarcinoma.

Miyasaka M, Noji T, Ohtaka K, Chiba R, Sato S, Shoji Y, Hase R, Ichimura T, Hirano S, Senmaru N.

Clin J Gastroenterol. 2018 Feb;11(1):53-61. doi: 10.1007/s12328-017-0781-9. Epub 2017 Oct 16.

PMID:
29039114
49.

A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.

Murahashi S, Takahari D, Wakatsuki T, Fukuda N, Ichimura T, Ogura M, Ozaka M, Shinozaki E, Nakayama I, Matsushima T, Osumi H, Chin K, Yamaguchi K.

Int J Clin Oncol. 2018 Feb;23(1):92-97. doi: 10.1007/s10147-017-1192-0. Epub 2017 Sep 14.

PMID:
28913565
50.

Mesh penetrating the cecum and bladder following inguinal hernia surgery: a case report.

Asano H, Yajima S, Hosoi Y, Takagi M, Fukano H, Ohara Y, Shinozuka N, Ichimura T.

J Med Case Rep. 2017 Sep 14;11(1):260. doi: 10.1186/s13256-017-1435-8.

Supplemental Content

Loading ...
Support Center